FY2025 · ended Dec 31, 2025 · Revenue $3.18B, +56.4% YoY · Filed Mar 12, 2026
Astrana Health, Inc. (ASTH) files with the SEC under industry code 8742, Services-Management Consulting Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.2 billion and net income of $22.5 million. Free cash flow was $104.5 million. As of Jun 30, 2026 it held $402.1 million in cash and investments and $979.4 million in total debt.
Revenue (TTM)
$3.84B
+58.9% vs year-ago TTM
Net income (TTM)
$40.55M
+60.5% vs year-ago TTM
Operating cash flow (TTM)
$107.87M
-17.4% vs year-ago TTM
Free cash flow (TTM)
$94.38M
-22.2% vs year-ago TTM
EPS (TTM)
$0.82
+57.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
55.60M
-1.2% vs prior year
Net cash
$-577.27M
as of Jun 30, 2026
Operating margin
2.6%
FY 2026
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- ASTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alhambra, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1083446
- Former names
- Apollo Medical Holdings, Inc. (until Feb 13, 2024); SICLONE INDUSTRIES INC (until Jul 15, 2008)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- ICF International, Inc. ICFI
- Bowman Consulting Group Ltd. BWMN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | $773.9M |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | $98.2M |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | $68.9M |
| Diluted EPS | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 |
| Operating cash flow | $114.6M | $52.2M | $68.2M | $82.1M | $70.3M |
| Free cash flow | $104.5M | $44.2M | $39.7M | $59.2M | $51.1M |
| Total assets | $2.2B | $1.4B | $933.4M | $966.2M | $867.4M |
| Total liabilities | $1.7B | $840.7M | $522.6M | $407.7M | $356.7M |
| Stockholders' equity | $779.3M | $712.7M | $614.2M | $542.6M | $448.2M |
| Cash and investments | $429.6M | $290.8M | $296.3M | $293.6M | $286.5M |
| Total debt | $1.1B | $471.8M | $321.0M | $229.4M | $201.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K | Current report | Sep 23, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 13, 2026 | Jul 13, 2026 |
All 1000 Astrana Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.